Part Number
Part Number:
NSN:
NIIN:
Item Name:
DIAZOXIDE INJECTION , USP
Definition:
CAGE Information
| Code | Company |
|---|---|
| 1F095 | SCHERING-PLOUGH CORPORATION |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DIAZOXIDE INJECTION USP 300MG 20ML AMPUL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DIAZOXIDE INJECTION USP 300MG 20ML AMPUL |
| SUPP | SUPPLEMENTARY FEATURES | FOR INTRAVENOUS USE ONLY |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 20.000 MILLILITERS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS DIAZOXIDE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | AMPUL |
| AJCN | PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| CSGS | ADMINISTRATION | INTRAVENOUS |